Skip to main content
Clinical Trials/NCT01865097
NCT01865097
Unknown
Phase 1

Pilot Study of Relaxation Guided Imagery for Treatment of Pain in Parkinson's Disease

Rambam Health Care Campus0 sites50 target enrollmentJune 2013

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Parkinson's Disease
Sponsor
Rambam Health Care Campus
Enrollment
50
Primary Endpoint
Pain scores on the visual analog scale
Last Updated
11 years ago

Overview

Brief Summary

Parkinson's disease patients may have severe non-motor symptoms. A common and troublesome non-motor symptom is pain. Currently these symptoms are treated with medication with limited success. Our study aims to determine whether relaxation guided imagery can alleviate pain in Parkinson's disease patients.

Detailed Description

Parkinson's disease patients with severe pain without dementia will participate in this study aimed to examine a possible beneficial effect of relaxation guided imagery on pain. This will be a phase I, controlled, single blind and randomized efficacy study in 2 parallel groups. The study will include a baseline assessment of pain severity where after the intervention group will undergo relaxation guided imagery and the control group will listen to relaxing music. After these relaxation session patients will receive a CD with either relaxation guided imagery or relaxing music to listen to at home. Pain severity will be recorded for the following 6 weeks.

Registry
clinicaltrials.gov
Start Date
June 2013
End Date
December 2015
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr. Ilana Schlesinger

Director, Movement Disorders Center

Rambam Health Care Campus

Eligibility Criteria

Inclusion Criteria

  • Patients with idiopathic Parkinson's disease suffering from significant pain.

Exclusion Criteria

  • Hearing impairment

Outcomes

Primary Outcomes

Pain scores on the visual analog scale

Time Frame: 6 weeks

Numeric rating scale after relaxation guided imagery as compared with baseline

Secondary Outcomes

  • The brief Pain Inventory(6 weeks)

Similar Trials